Reply to Letter by Cyrta et al, Entitled "Additional Considerations on Aberrant BRG1 (SMARCA4) Expression in Small Cell Carcinoma of the Ovary, Hypercalcemic Type (SCCOHT)"

MeSH terms

• Biomarkers, Tumor* / analysis
• Biomarkers, Tumor* / genetics
• Carcinoma, Small Cell* / genetics
• Carcinoma, Small Cell* / pathology
• DNA Helicases* / genetics
• Female
• Humans
• Hypercalcemia*
• Nuclear Proteins* / genetics
• Ovarian Neoplasms* / genetics
• Ovarian Neoplasms* / pathology
• Transcription Factors* / genetics